Sarcopenia in Chronic Liver Diseases
Khattab, M., El-Amin, N., Abdel-Aziz, M., Saleeb, V. (2019). Sarcopenia in Chronic Liver Diseases. EKB Journal Management System, 30(3), 100-104. doi: 10.21608/mjmr.2022.221879
Mahmoud A. Khattab; Nadia F. El-Amin; Mohamed O. Abdel-Aziz; Victoria M. Saleeb. "Sarcopenia in Chronic Liver Diseases". EKB Journal Management System, 30, 3, 2019, 100-104. doi: 10.21608/mjmr.2022.221879
Khattab, M., El-Amin, N., Abdel-Aziz, M., Saleeb, V. (2019). 'Sarcopenia in Chronic Liver Diseases', EKB Journal Management System, 30(3), pp. 100-104. doi: 10.21608/mjmr.2022.221879
Khattab, M., El-Amin, N., Abdel-Aziz, M., Saleeb, V. Sarcopenia in Chronic Liver Diseases. EKB Journal Management System, 2019; 30(3): 100-104. doi: 10.21608/mjmr.2022.221879

Sarcopenia in Chronic Liver Diseases

Minia Journal of Medical Research
Article 19, Volume 30, Issue 3, July 2019, Page 100-104  XML PDF (416.84 K)
Document Type: Original Article
DOI: 10.21608/mjmr.2022.221879
View on SCiNiTO View on SCiNiTO
Authors
Mahmoud A. Khattab1; Nadia F. El-Amin2; Mohamed O. Abdel-Aziz1; Victoria M. Saleeb3
1Department of Internal Medicine, Faculty of Medicine, Minia University, P O:61111
2Department of Radiology, faculty of Medicine, Minia University, PO: 61111
3Department of Internal Medicine, Faculty of Medicine, Minia University, P O:61111.
Abstract
Background: Sarcopenia is defined as a muscle mass two standard deviations below the 
healthy young adult mean, and although it is associated with aging, it can also be present as a 
result of chronic diseases and malignancy, and it ultimately leads to decreased functional 
capacity and higher risk of morbidity and mortality in different groups of patients. Aim of 
The work: The aim of this study is to investigate the frequency of sarcopenia in HCV 
induced chronic liver diseases. Subjects and Methods: This case control hospital based study 
recruited patients with HCV-induced chronic liver disease of different functional grades 
according to Child-Pough and Meld scores and a group of healthy subjects as controls. All 
participants were assessed for demographic, hematological, and biochemical liver and renal 
profiles. Radiological diagnostic parameters of sarcopenia were determined by subjecting all 
participants to MDCT abdominal scan at the level of psoas muscle. Results: Using computed 
tomography measurement of psoas muscle thickness/height as a diagnostic validated test for 
sarcopenia, sarcopenia was detected in 52.5% of our liver cirrhosis patients. Conclusion and 
future recommendations In conclusion, sarcopenia is a common complication of cirrhosis 
and adversely affects survival, quality of life, and response to stress including infection and 
surgery.

Keywords
Sarcopenia; HCV; Cirrhosis. 
Supplementary Files
Statistics
Article View: 80
PDF Download: 143